Table 4.

Outcomes^* from published AS cohorts with median follow-up ≥ five years, 2010–2015.

	N	GS ≥7 (%)	Median follow-up, (yrs.)	5-year treated	10-year treated	BCR after Tx	Mets	PCSM	10-year PCSM	15-year PCSM	OM
Johns Hopkins	1298	0	5.0	37	50	8%	0.4%	0.15%	0.1%	0.1%	4%
Sunnybrook	993	13	6.4	24	36	25%**	2.8%	1.5%	1.9%	5.7%	15%
Göteborg	439	NR†	6.0	39	55	9%	0.5%	0.2%			14%
UCSF	810	8	5.0	40		3% (1yr) #	0.1%	0%			2%^
Royal Marsden	471	7	5.7	30		7% (2yr)**		0.4%			6%

^*Time-specific rates provided when available. Otherwise, values represent crude proportions which are dependent on follow-up

^†NR=Not reported. 22% of men met ≥1 intermediate risk criterion

^**5-year BCR: 23% (Sunnybrook), 15% (Royal Marsden)

^#RP treated patients only

^{^}5-year time to event